Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosisBenedikt Hofer, Thomas Reiberger, Mattias Mandorfer et al.|United European Gastroenterology Journal|2024Cited by 8
WED-122-YI The soluble guanylate cyclase pathway is dysregulated in rodent models of cirrhosis and portal hypertensionThomas Sorz‐Nechay, Thomas Reiberger, Ksenia Brusilovskaya et al.|Journal of Hepatology|2024Cited by 0
WED-125 Differential regulation of soluble guanylate cyclase signaling during liver fibrosis regressionThomas Sorz‐Nechay, Thomas Reiberger, Ksenia Brusilovskaya et al.|Journal of Hepatology|2024Cited by 0
FRI-058-YI Time-resolved liver fibrosis regression at single-cell resolution in a murine CCl4-cessation modelKatharina Bonitz, Thomas Reiberger, Thomas Sorz‐Nechay et al.|Journal of Hepatology|2025Cited by 0
THU-486 The anticoagulant Edoxaban improves portal hypertension and liver injury in progressive liver diseaseKatharina Bonitz, Benedikt Hofer, Henriette Horstmeier et al.|Journal of Hepatology|2025Cited by 0